Cargando…

Prostatic displacement during extreme hypofractionated radiotherapy using volumetric modulated arc therapy (VMAT)

BACKGROUND: To determine prostate displacement during extreme hypofractionated volume modulated arc radiotherapy (VMAT) using pre- and post-treatment orthogonal images with three implanted gold seed fiducial markers. METHODS: A total of 150 image pairs were obtained from 30 patients who underwent ex...

Descripción completa

Detalles Bibliográficos
Autores principales: Gladwish, Adam, Pang, Geordi, Cheung, Patrick, D’Alimonte, Laura, Deabreu, Andrea, Loblaw, Andrew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4251941/
https://www.ncbi.nlm.nih.gov/pubmed/25430973
http://dx.doi.org/10.1186/s13014-014-0262-y
_version_ 1782347120731226112
author Gladwish, Adam
Pang, Geordi
Cheung, Patrick
D’Alimonte, Laura
Deabreu, Andrea
Loblaw, Andrew
author_facet Gladwish, Adam
Pang, Geordi
Cheung, Patrick
D’Alimonte, Laura
Deabreu, Andrea
Loblaw, Andrew
author_sort Gladwish, Adam
collection PubMed
description BACKGROUND: To determine prostate displacement during extreme hypofractionated volume modulated arc radiotherapy (VMAT) using pre- and post-treatment orthogonal images with three implanted gold seed fiducial markers. METHODS: A total of 150 image pairs were obtained from 30 patients who underwent extreme hypofractionated radiotherapy to a dose of 40 Gy in five fractions on standard linear accelerators. Position verification was obtained with orthogonal x-rays before and after treatment and were used to determine intra-fraction prostate displacement. RESULTS: The mean prostate displacements were 0.03 ± 1.23 mm (1SD), 0.18 ± 1.55 mm, and 0.37 ± 1.95 mm in the left-right, superior-inferior, and anterior-posterior directions, respectively. The mean 3D displacement was 2.32 ± 1.55 mm. Only 6 (4%) fractions had a 3D displacement of >5 mm. The average time of treatment delivery for a given fraction was 195 ± 59 seconds. CONCLUSIONS: The mean intra-fraction prostate displacement during a course of extreme hypofractionated radiotherapy delivered via VMAT, continues to be small. Clinical margins typically used in a similar fixed-angle IMRT treatment are adequate. The use of VMAT in further extreme hypofractionation may limit prostatic motion uncertainties that would be otherwise be associated with longer treatment times.
format Online
Article
Text
id pubmed-4251941
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-42519412014-12-04 Prostatic displacement during extreme hypofractionated radiotherapy using volumetric modulated arc therapy (VMAT) Gladwish, Adam Pang, Geordi Cheung, Patrick D’Alimonte, Laura Deabreu, Andrea Loblaw, Andrew Radiat Oncol Research BACKGROUND: To determine prostate displacement during extreme hypofractionated volume modulated arc radiotherapy (VMAT) using pre- and post-treatment orthogonal images with three implanted gold seed fiducial markers. METHODS: A total of 150 image pairs were obtained from 30 patients who underwent extreme hypofractionated radiotherapy to a dose of 40 Gy in five fractions on standard linear accelerators. Position verification was obtained with orthogonal x-rays before and after treatment and were used to determine intra-fraction prostate displacement. RESULTS: The mean prostate displacements were 0.03 ± 1.23 mm (1SD), 0.18 ± 1.55 mm, and 0.37 ± 1.95 mm in the left-right, superior-inferior, and anterior-posterior directions, respectively. The mean 3D displacement was 2.32 ± 1.55 mm. Only 6 (4%) fractions had a 3D displacement of >5 mm. The average time of treatment delivery for a given fraction was 195 ± 59 seconds. CONCLUSIONS: The mean intra-fraction prostate displacement during a course of extreme hypofractionated radiotherapy delivered via VMAT, continues to be small. Clinical margins typically used in a similar fixed-angle IMRT treatment are adequate. The use of VMAT in further extreme hypofractionation may limit prostatic motion uncertainties that would be otherwise be associated with longer treatment times. BioMed Central 2014-11-28 /pmc/articles/PMC4251941/ /pubmed/25430973 http://dx.doi.org/10.1186/s13014-014-0262-y Text en © Gladwish et al.; licensee BioMed Central Ltd. 2014 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Gladwish, Adam
Pang, Geordi
Cheung, Patrick
D’Alimonte, Laura
Deabreu, Andrea
Loblaw, Andrew
Prostatic displacement during extreme hypofractionated radiotherapy using volumetric modulated arc therapy (VMAT)
title Prostatic displacement during extreme hypofractionated radiotherapy using volumetric modulated arc therapy (VMAT)
title_full Prostatic displacement during extreme hypofractionated radiotherapy using volumetric modulated arc therapy (VMAT)
title_fullStr Prostatic displacement during extreme hypofractionated radiotherapy using volumetric modulated arc therapy (VMAT)
title_full_unstemmed Prostatic displacement during extreme hypofractionated radiotherapy using volumetric modulated arc therapy (VMAT)
title_short Prostatic displacement during extreme hypofractionated radiotherapy using volumetric modulated arc therapy (VMAT)
title_sort prostatic displacement during extreme hypofractionated radiotherapy using volumetric modulated arc therapy (vmat)
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4251941/
https://www.ncbi.nlm.nih.gov/pubmed/25430973
http://dx.doi.org/10.1186/s13014-014-0262-y
work_keys_str_mv AT gladwishadam prostaticdisplacementduringextremehypofractionatedradiotherapyusingvolumetricmodulatedarctherapyvmat
AT panggeordi prostaticdisplacementduringextremehypofractionatedradiotherapyusingvolumetricmodulatedarctherapyvmat
AT cheungpatrick prostaticdisplacementduringextremehypofractionatedradiotherapyusingvolumetricmodulatedarctherapyvmat
AT dalimontelaura prostaticdisplacementduringextremehypofractionatedradiotherapyusingvolumetricmodulatedarctherapyvmat
AT deabreuandrea prostaticdisplacementduringextremehypofractionatedradiotherapyusingvolumetricmodulatedarctherapyvmat
AT loblawandrew prostaticdisplacementduringextremehypofractionatedradiotherapyusingvolumetricmodulatedarctherapyvmat